PMDD Treatment Options: Beyond 'It's Just PMS'

Every month, like clockwork, you become a different person. Not just irritable or bloated — emotionally devastated. Crying over nothing. Rage that feels disproportionate to the situation but completely real in the moment. Anxiety so intense you can't function at work. Hopelessness that makes you question your relationships, your career, your worth. Then your period starts, and within a day or two, you're fine again. Until next month.

If this sounds familiar, you may have premenstrual dysphoric disorder — PMDD. And no, it is not just "bad PMS."

What PMDD Actually Is

PMDD is a hormone-sensitive mood disorder that affects approximately 5-8% of menstruating women. It was officially recognized in the DSM-5 as a depressive disorder in 2013, which means for decades, women with PMDD were told they were being dramatic, hormonal, or simply needed to "push through it."

The key distinction between PMS and PMDD is severity and the predominance of mood symptoms. PMS might make you uncomfortable. PMDD can make you non-functional. It causes clinically significant distress or impairment in work, social activities, or relationships.

Diagnostic Criteria

To meet the diagnostic criteria for PMDD, you must experience at least five of the following symptoms during the week before your period, with improvement within a few days after your period starts, and minimal or no symptoms in the week after your period:

At least one of these must be present:

• Marked mood swings, sudden sadness, or increased sensitivity to rejection
• Marked irritability, anger, or increased interpersonal conflicts
• Markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts
• Marked anxiety, tension, or feeling keyed up or on edge

Plus enough of these to total five symptoms:

• Decreased interest in usual activities
• Difficulty concentrating
• Lethargy, fatigue, or marked lack of energy
• Marked change in appetite, overeating, or specific food cravings
• Hypersomnia or insomnia
• Feeling overwhelmed or out of control
• Physical symptoms such as breast tenderness, bloating, joint or muscle pain, or weight gain

The symptoms must have been present for most menstrual cycles during the past year, and they must not be an exacerbation of another disorder like major depression or anxiety.

Why PMDD Happens

PMDD is not caused by abnormal hormone levels. Women with PMDD typically have normal estrogen and progesterone levels. The problem is an abnormal central nervous system response to normal hormonal fluctuations.

Research points to altered sensitivity of the GABA-A receptor system to allopregnanolone — a neurosteroid metabolite of progesterone. In most women, allopregnanolone has a calming, anxiety-reducing effect. In women with PMDD, the brain's response to this neurosteroid appears to be dysfunctional, potentially even paradoxical.

There is also evidence of serotonergic dysregulation during the luteal phase, which explains why SSRIs are so effective for PMDD — sometimes at lower doses than needed for depression, and sometimes only when taken during the luteal phase.

Genetic factors play a role. Studies have identified a gene complex (ESC/E(Z)) involved in the cellular response to estrogen and progesterone that is differentially expressed in women with PMDD compared to controls.

Treatment Options That Actually Work

SSRIs: The First-Line Treatment

Selective serotonin reuptake inhibitors are the most evidence-based treatment for PMDD, and they work differently here than they do for depression. A [2024 Cochrane systematic review of SSRIs for PMS/PMDD](https://pubmed.ncbi.nlm.nih.gov/39140320/) confirmed that SSRIs — including continuous and luteal-phase regimens — meaningfully reduce premenstrual symptoms compared with placebo.

For depression, SSRIs take 4-6 weeks to reach full effect. For PMDD, they can work within days — sometimes within the first dose. This rapid onset suggests they're working through a different mechanism (likely direct neurosteroid modulation rather than the slow serotonin receptor changes that treat depression).

FDA-approved SSRIs for PMDD:

• Fluoxetine (Prozac/Sarafem) — 20mg
• Sertraline (Zoloft) — 50-150mg
• Paroxetine (Paxil CR) — 12.5-25mg

Dosing strategies:

• Continuous dosing — take the SSRI every day of the cycle. Best for women who also have underlying depression or anxiety.
• Luteal phase dosing — take the SSRI only during the last 14 days of the cycle (from ovulation to period onset). Effective and minimizes side effects and cost.
• Symptom-onset dosing — start the SSRI when symptoms begin. Some evidence supports this approach for women with predictable symptom onset.

At CORAL, Dr. Kim works with each patient to determine which dosing strategy makes the most sense based on symptom patterns, side effect tolerance, and lifestyle.

Hormonal Approaches

Since PMDD symptoms are triggered by the hormonal fluctuations of the menstrual cycle, eliminating those fluctuations can eliminate PMDD:

Combined oral contraceptives — Yaz (drospirenone/ethinyl estradiol) is FDA-approved for PMDD. The 24/4 dosing regimen (24 active pills, 4 placebo) is superior to the traditional 21/7 regimen for PMDD because it minimizes hormone-free days. Continuous dosing (skipping placebo pills) may provide even better control.

GnRH agonists — Medications like leuprolide (Lupron) create a temporary medical menopause by suppressing ovarian function. Highly effective for PMDD, but side effects include menopausal symptoms and bone loss. Typically used with "add-back" estrogen/progesterone therapy to mitigate these effects. Reserved for severe, refractory cases.

Progesterone — Despite the role of progesterone metabolites in PMDD pathophysiology, progesterone supplementation alone has not shown consistent benefit in clinical trials. This is counterintuitive but well-established.

Lifestyle and Supplement Approaches

These should complement, not replace, evidence-based pharmacological treatment for moderate-to-severe PMDD:

• Calcium (1,200 mg/day) — Multiple studies show significant reduction in PMDD symptoms. One of the best-studied supplements for this condition.
• Vitamin B6 (50-100 mg/day) — Some evidence of benefit, though quality of studies is mixed. Don't exceed 100mg due to neuropathy risk.
• Chasteberry (Vitex agnus-castus) — Limited evidence of benefit for premenstrual symptoms, though study quality is low.
• Regular aerobic exercise — 30-60 minutes most days. Consistent evidence of reduced PMS/PMDD severity.
• Stress reduction — Cognitive behavioral therapy (CBT), mindfulness-based stress reduction, and other stress management techniques show benefit as adjunctive treatment.
• Sleep hygiene — Prioritize consistent sleep timing, especially during the luteal phase when sleep architecture is disrupted.
• Dietary modifications — Reducing caffeine, alcohol, salt, and refined sugar during the luteal phase may reduce symptom severity for some women.

Emerging and Off-Label Treatments

• Sepranolone — A progesterone metabolite that blocks the negative effects of allopregnanolone at the GABA-A receptor. Phase III trials have shown promising results specifically targeting the hormonal mechanism of PMDD.
• Dutasteride — A 5-alpha reductase inhibitor that blocks the conversion of progesterone to allopregnanolone. Early clinical data is encouraging but not yet standard of care.
• Ulipristal acetate — A progesterone receptor modulator showing benefit in preliminary studies.

Tracking Your Symptoms

Accurate diagnosis of PMDD requires prospective daily symptom tracking for at least two consecutive menstrual cycles. Retrospective recall ("I think my symptoms are worse before my period") is not sufficient for diagnosis because recall bias inflates symptom severity.

Use a validated tool like the Daily Record of Severity of Problems (DRSP) or a tracking app that captures daily ratings of mood, physical symptoms, and functional impairment across the entire cycle.

The pattern you're looking for: symptoms that consistently escalate during the luteal phase (the 14 days before your period), peak in the days before menstruation, and resolve within a few days of period onset. If symptoms persist throughout the cycle without a clear symptom-free window, the diagnosis may be something else — major depression, generalized anxiety, or another condition that worsens premenstrually but is always present.

When PMDD Coexists with Other Conditions

PMDD frequently co-occurs with:

• Major depression — Women with PMDD have a higher lifetime risk of depression. Continuous SSRI dosing may address both conditions simultaneously.
• Anxiety disorders — Generalized anxiety and PMDD share serotonergic mechanisms. Treatment often overlaps.
• ADHD — Hormonal fluctuations can worsen ADHD symptoms during the luteal phase. Stimulant dose adjustments may be needed.
• Bipolar disorder — Important to distinguish PMDD from premenstrual exacerbation of bipolar disorder, as treatment differs significantly (SSRIs can trigger mania in bipolar disorder).

Getting Help

PMDD is a real, physiological condition with effective treatments. You do not need to lose a week of your life every month. You do not need to damage relationships during your luteal phase and then spend the rest of the month repairing them. You do not need to dread half your menstrual cycle.

If you suspect you have PMDD, start tracking your symptoms daily for two cycles, then [schedule a visit at coral.clinic/start](https://coral.clinic/start). Dr. Kim can review your symptom patterns, confirm the diagnosis, and develop a treatment plan that works with your cycle rather than against it.